相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells
L. C. Sjoberg et al.
ALLERGY (2015)
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
Dawn K. Reichenbach et al.
BLOOD (2015)
The biology of graft-versus-host disease: experimental systems instructing clinical practice
Kate A. Markey et al.
BLOOD (2014)
Acute graft-versus-host disease: a bench-to-bedside update
Shernan G. Holtan et al.
BLOOD (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
Current and emerging strategies for the prevention of graft-versus-host disease
Sung Won Choi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
IL-33/ST2 axis promotes mast cell survival via BCLXL
Jun-Xia Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers
Yong Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells
Dennis B. Leveson-Gower et al.
BLOOD (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity
Kwangwon Hong et al.
IMMUNOLOGIC RESEARCH (2013)
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
Mark T. Vander Lugt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
E. H. Warren et al.
TISSUE ANTIGENS (2013)
Th9 cells promote antitumor immune responses in vivo
Yong Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo
C. Cocco et al.
LEUKEMIA (2012)
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama et al.
NATURE MEDICINE (2012)
Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction
Sergio Manzano-Fernandez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Soluble ST2 Is a Marker for Acute Cardiac Allograft Rejection
Domingo A. Pascual-Figal et al.
ANNALS OF THORACIC SURGERY (2011)
Type I-IFNs control GVHD and GVL responses after transplantation
Renee J. Robb et al.
BLOOD (2011)
Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
Isao Tawara et al.
CLINICAL CANCER RESEARCH (2011)
Generation and Characterization of Rat Anti-mouse ST2L Monoclonal Antibodies
Natalie Fursov et al.
HYBRIDOMA (2011)
IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin-33 prolongs allograft survival during chronic cardiac rejection
Stefan M. Brunner et al.
TRANSPLANT INTERNATIONAL (2011)
Soluble ST2: A new and promising activity marker in ulcerative colitis
David Diaz-Jimenez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease
John M. Magenau et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Granzymes in cancer and immunity
S. P. Cullen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
Elvire Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
BLOOD (2008)
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells
Britt E. Anderson et al.
BLOOD (2008)
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice
Pavan Reddy et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Tim C. P. Somervaille et al.
CANCER CELL (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Prophylaxis and treatment of acute graft-versus-host disease
NJ Chao et al.
SEMINARS IN HEMATOLOGY (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing
B Johansson-Lindbom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn et al.
BLOOD (2005)
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
PJ Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
K Oshikawa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
VT Ho et al.
BLOOD (2001)
分享论文
